Evidence map›Paper›PMID 30272672›Full record

ArticleJournal of visualized experiments : JoVE2018

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

George M Solomon, Inez Bronsveld, Kathryn Hayes, Michael Wilschanski, Paola Melotti, Steven M Rowe, Isabelle Sermet-Gaudelus

Registry-linked trialOpen access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07402434 (Advanced Diagnostic Validation and Novel Clinical Evaluation Across the CFTR Spectrum), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07402434 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Advanced Diagnostic Validation and Novel Clinical Evaluation Across the CFTR Spectrum (ADVANCE-CFTR): a Prospective Study of CFTR Functional Assays, Including Rectal Organoids, to Improve the Accuracy of Diagnosing Cystic Fibrosis.

TypeobservationalSponsorRoyal Brompton & Harefield NHS Foundation TrustRan2026 to 2028Enrolled80ConditionsCystic Fibrosis (CF), CFTR-related DisordersArmsRectal Biopsy, Rectal biopsy taken opportunistically during endoscopy procedure for other reasons., Blood test for CFTR Genotyping
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Toward in vivo bronchoscopic functional CFTR assessment using a short circuit current measurement probe.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  5. Article
  6. Article
  7. Assays of CFTR Function In Vitro, Ex Vivo and In Vivo.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

George M SolomonDepartment of Medicine and the Gregory Fleming James Cystic Fibrosis Center, University of Alabama at Birmingham.
Inez BronsveldDepartment of Pulmonology and Tuberculosis, University Medical Center Utrecht.
Kathryn HayesCenter for Experimental Medicine, Queens University, Northern Ireland.
Michael WilschanskiHadassah Hebrew University Medical Center, Jerusalem.
Paola MelottiCentro Fibrosi Cistica, Azienda Ospedaliera Universitaria Integrata.
Steven M RoweDepartment of Medicine and the Gregory Fleming James Cystic Fibrosis Center, University of Alabama at Birmingham.
Isabelle Sermet-GaudelusService de Pneumologie et Allergologie Pédiatriques and Center de Ressources et de Compétence de la Mucoviscidose, Hôpital Necker Enfants Malades; INSERM U 1151, Institut Necker Enfants Malades; isabelle.sermet@nck.aphp.fr.
University of Alabama at Birmingham · USHôpital Necker-Enfants Malades · FRUniversity Medical Center · USUniversity Medical Center Utrecht · NL

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

We describe a standardized measurement of nasal potential difference (NPD). In this technique, cystic fibrosis transmembrane conductance regulator (CFTR) and the epithelial sodium channel (ENaC) function are monitored by the change in voltage across the nasal epithelium after the superfusion of solutions that modify ion channel activity. This is enabled by the measurement of the potential difference between the subcutaneous compartment and the airway epithelium in the nostril, utilizing a catheter in contact with the inferior nasal turbinate. The test allows the measurement of the stable baseline voltage and the successive net voltage changes after perfusion of 100 µM amiloride, an inhibitor of Na

Indexed as

Cystic FibrosisHumansMembrane PotentialsNasal Mucosa

Identifiers

PMID30272672
PMCPMC6235174
OpenAlexW2890998576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.